Journal
CELL
Volume 173, Issue 4, Pages 815-817Publisher
CELL PRESS
DOI: 10.1016/j.cell.2018.04.020
Keywords
-
Categories
Funding
- NIH/NCI [CA087660, CA132630]
Ask authors/readers for more resources
Matching genetically defined cancer states to drugs that specifically target these states is a principal goal of personalized oncology medicine. In this issue, McMillan et al. show how large-scale chemical screening coupled to deep molecular profiling can identify mechanistically diverse druggable vulnerabilities for genetic subtypes of lung cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available